Title : The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma.

Pub. Date : 2018 Dec 15

PMID : 30101910






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Objective Although R-CHOP (rituximab, cyclophosphamide, vincristine, doxorubicin, and prednisone) is a standard therapy for diffuse large B-cell lymphoma (DLBCL), the optimal dose for elderly patients remains unclear. Cyclophosphamide DNA damage inducible transcript 3 Homo sapiens